ClinVar Miner

Submissions for variant NM_032043.3(BRIP1):c.1433A>G (p.His478Arg)

gnomAD frequency: 0.00002  dbSNP: rs45501097
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 15
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000120388 SCV000150034 benign not specified 2018-02-28 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Labcorp Genetics (formerly Invitae), Labcorp RCV001084447 SCV000166671 benign Familial cancer of breast; Fanconi anemia complementation group J 2024-01-29 criteria provided, single submitter clinical testing
Ambry Genetics RCV000116125 SCV000183881 benign Hereditary cancer-predisposing syndrome 2019-05-07 criteria provided, single submitter clinical testing This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Counsyl RCV000409336 SCV000489881 benign Fanconi anemia complementation group J 2016-07-11 criteria provided, single submitter clinical testing
Counsyl RCV000410488 SCV000489882 benign Ovarian neoplasm 2016-07-11 criteria provided, single submitter clinical testing
Quest Diagnostics Nichols Institute San Juan Capistrano RCV000514890 SCV000600893 benign not provided 2022-03-29 criteria provided, single submitter clinical testing
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics RCV000514890 SCV000610616 likely benign not provided 2017-05-11 criteria provided, single submitter clinical testing
Color Diagnostics, LLC DBA Color Health RCV000116125 SCV000689260 benign Hereditary cancer-predisposing syndrome 2017-11-12 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000409336 SCV001283866 benign Fanconi anemia complementation group J 2018-01-12 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
National Health Laboratory Service, Universitas Academic Hospital and University of the Free State RCV002225333 SCV002505037 benign Hereditary breast ovarian cancer syndrome 2022-04-19 criteria provided, single submitter clinical testing
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital RCV000120388 SCV002760982 benign not specified 2023-08-15 criteria provided, single submitter clinical testing
KCCC/NGS Laboratory, Kuwait Cancer Control Center RCV003315647 SCV004016921 benign Familial cancer of breast 2023-07-07 criteria provided, single submitter clinical testing
Myriad Genetics, Inc. RCV003315647 SCV004019482 likely benign Familial cancer of breast 2023-03-02 criteria provided, single submitter clinical testing This variant is considered likely benign. This variant has been observed at a population frequency that is significantly greater than expected given the associated disease prevalence and penetrance.
ITMI RCV000120388 SCV000084540 not provided not specified 2013-09-19 no assertion provided reference population
Department of Pathology and Laboratory Medicine, Sinai Health System RCV000514890 SCV001548876 likely benign not provided no assertion criteria provided clinical testing The BRIP1 p.His478Arg variant was identified in 1 of 2520 proband chromosomes (frequency: 0.0004) from individuals or families with Lynch syndrome (Yurgelun 2015). The variant was also identified in dbSNP (ID: rs45501097) as With Uncertain significance allele, ClinVar (classified as benign by Invitae, Counsyl; classified as likely benign by GeneDx; classified as uncertain significance by Ambry Genetics), Zhejiang Colon Cancer Database, databases. The variant was not identified in the Cosmic or MutDB databases. The variant was identified in control databases in 493 (8 homozygous) of 270132 chromosomes at a frequency of 0.002 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Consortium Feb 27, 2017). The variant was identified in the following populations at a frequency greater than 1%: South Asian in 480 of 29928 chromosomes (freq: 0.016). The p.His478 residue is not conserved in mammals and four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) do not predict a difference in splicing. The variant is located with the DNA helicase (DNA repair), Rad3 type functional domain the clinical significance of which is not known. In summary, based on the above information, the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.